Inhibition of Aβ Aggregation by Cholesterol-End-Modified PEG Vesicles and Micelles

Inhibition of Aβ Aggregation by Cholesterol-End-Modified PEG Vesicles and Micelles

<b>Background/Objectives</b>: This study aimed to design and evaluate Chol-PEG<sub>2000</sub> micelles and Chol-PEG<sub>500</sub> vesicles as drug delivery system (DDS) carriers and inhibitors of amyloid-β (Aβ) aggregation, a key factor in Alzheimer’s disease (AD)...

Full description

Saved in:
Bibliographic Details
Main Authors: Shota Watanabe, Motoki Ueda, Shoichiro Asayama
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmaceutics
Subjects:
Alzheimer’s disease
Aβ aggregation
drug delivery carrier
micelle
vesicle
cholesterol-end-modified PEG (Chol-PEG)
Online Access:https://www.mdpi.com/1999-4923/17/1/1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items